Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.
Latest Information Update: 31 Mar 2025
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Pharmacodynamics
- 27 Mar 2025 Planned End Date changed from 31 Dec 2024 to 31 Dec 2026.
- 27 Mar 2025 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2026.
- 13 May 2024 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.